KEAP1 and neoplasm: Importantly, this unbiased screening identified several hits that positively regulate PRMT5 expression, including oncoproteins such as HRAS and BRAF, whereas tumor suppressors like KEAP1 were identified as top-scoring hits that negatively regulate PMRT5 levels (Figure 3, B and C).